tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

MedPlus Health Revises Access Details for Q3 FY2026 Earnings Call

Story Highlights
  • MedPlus Health corrected an erroneous joining link for its December quarter earnings call.
  • Updated access and dial-in details aim to ensure smooth participation by investors and analysts.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
MedPlus Health Revises Access Details for Q3 FY2026 Earnings Call

Claim 50% Off TipRanks Premium

The latest announcement is out from MedPlus Health Services Ltd. ( (IN:MEDPLUS) ).

MedPlus Health Services Limited has issued a revised intimation regarding its earnings call for the quarter ended December 31, 2025, scheduled on February 2, 2026, after discovering that the earlier joining link shared with analysts and institutional investors was incorrect. The company has now provided an updated access link and detailed dial-in information, including international toll-free numbers, and noted that the corrected information is also available on its own website as well as on the BSE and NSE platforms, ensuring stakeholders have accurate details to participate in the call and mitigating any potential disruption to its investor communications.

More about MedPlus Health Services Ltd.

MedPlus Health Services Limited is an Indian healthcare and pharmacy services company operating a large retail network of medical stores, with a focus on providing pharmaceutical and healthcare products to consumers across various regions in India. The company is listed on both BSE and NSE, reflecting its position as a publicly traded player in the organized pharmacy retail segment.

Average Trading Volume: 21,248

Technical Sentiment Signal: Hold

Current Market Cap: 95.71B INR

Learn more about MEDPLUS stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1